First-Ever Self-Care Index Assesses Global Readiness to Boost Health System Resilience
22 sept. 2021 09h30 HE
|
The Global Self-Care Federation
Geneva, Switzerland, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The Global Self-Care Federation (GSCF) today announces the launch of a pioneering report for self-care, the Self-Care Readiness Index,...
Rita & Alex Hillman Foundation Announces New Grants to Spur Innovation and Advance Health Equity
21 sept. 2021 10h15 HE
|
Rita & Alex Hillman Foundation
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The Rita & Alex Hillman Foundation's Emergent Innovation Program (HEI) is announcing five new grants of $50,000 to support early stage,...
Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug
21 sept. 2021 07h00 HE
|
Clearmind Medicine
TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery...
Citizens for Mental Health Reform Calls for Signing of Petition to Re-Sentence All Psychiatric Security Review Board Clients
20 sept. 2021 14h05 HE
|
Citizens For Mental Health Reform
PORTLAND, Ore., Sept. 20, 2021 (GLOBE NEWSWIRE) -- The following is an open letter from Citizens For Mental Health Reform on our proposal to re-sentence all Oregon Psychiatric Security Review Board...
Novamind to Present at Life Sciences Investor Forum
15 sept. 2021 08h35 HE
|
Life Sciences Investor Forum
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Novamind Inc. (CSE: NM | OTCQB: NVMDF | FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is...
atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility Study Data
15 sept. 2021 08h10 HE
|
atai Life Sciences
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
Digital Mental Healthcare Provider Ahead Launches New Medication Management Service and Expands Provider Network
14 sept. 2021 09h00 HE
|
Ahead
SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ahead, the fast-growing tech-enabled mental healthcare platform, today announced the launch of a new medication management service. With a...
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression
14 sept. 2021 08h00 HE
|
atai Life Sciences
NEW YORK and BERLIN, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Perception Neuroscience (Perception), an atai Life Sciences (atai) biopharmaceutical company focused on developing innovative therapies in...
beingAI and MyXR Announce Strategic Partnership to Create Unique Gamification Experiences for Consumers Interacting with AI
14 sept. 2021 06h00 HE
|
MyXR Inc.
SAN FRANCISCO and HONG KONG, Sept. 14, 2021 (GLOBE NEWSWIRE) -- MyXR Inc., a global leader for SaaS XR and engagement software, and beingAI Limited, the world’s first transmedia AI company, announce...
atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression
09 sept. 2021 16h30 HE
|
atai Life Sciences
BERLIN and SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health...